DRAKE PETER F 4
4 · Trevi Therapeutics, Inc. · Filed May 13, 2019
Insider Transaction Report
Form 4
DRAKE PETER F
10% Owner
Transactions
- Conversion
Series A Preferred Stock
2019-05-09−133,153→ 0 total→ Common Stock (18,881 underlying) - Conversion
Series C Preferred Stock
2019-05-09−376,023→ 0 total→ Common Stock (43,659 underlying) - Conversion
Common Stock
2019-05-09+62,540→ 62,540 total
Footnotes (2)
- [F1]On May 9, 2019, the Series A Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F2]On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.